Consistent with literature on various cancers including hepatocellular Carcinoma [45], renal clear cell carcinoma [46], breast cancer [47], and pancreatic ductal adenocarcinoma [48], our study demonstrated that CDC20 is highly expressed in ACC and is associated with poor prognosis. This evidence concerns the gene CDC20 and hepatocellular carcinoma.